Cisplatin induces Sirt1 in association with histone deacetylation and increased Werner syndrome protein in the kidney

Clinical and Experimental Nephrology

Volumn 15, Issue 3, 2011, Pages 363-372

  Sakao, Yukitoshi ^a   Kato, Akihiko ^a   Tsuji, Takayuki ^a   Yasuda, Hideo ^a   Togawa, Akashi ^a   Fujigaki, Yoshihide ^a   Kahyo, Tomoaki ^a   Setou, Mitsutoshi ^a   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Deacetylation; Histone H3; Sirt1; Werner syndrome protein

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; CYCLINE; HISTONE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE H3; PROTEIN P53; SIRTUIN 1; WERNER SYNDROME PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DNA DAMAGE; KIDNEY CORTEX; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STABILITY; RAT; UPREGULATION; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; CISPLATIN; DNA HELICASES; HEK293 CELLS; HISTONE DEACETYLASES; HUMANS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959272067     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0421-5     Document Type: Article

References (32)

1. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 359-52.
2. Turner BM. Histone acetylation and control of gene expression. J Cell Sci. 1991;99:13-20.
3. Marumo T, Hishikawa K, Yoshikawa M, Fujita T. Epigenetic regulation of BMP7 in the regenerative response to ischemia. J Am Soc Nephrol. 2008;19:1311-20.
4. Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors. J Urol. 2008;180:1131-6.
5. Wang D, Lippard SJ. Cisplatin-induced post-translational modification of histone H3 and H4. J Biol Chem. 2004;279:20622-5.
6. Koul S, McKierman JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, et al. Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Mol Cancer. 2004;3:16.
7. Lin T, Liu PY, Marshall GM. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 2009;69:1702-5.
8. Luo J, Nikioaev AY, Imai S, Chen D, Su F, Shiloh A, et al. Negative control of p53 by Sir2a promotes cell survival under stress. Cell. 2001;107:137-48. (Pubitemid 33035941)
9. Vaziri H, Dessain SK, Eaton EN, Imai SI, Frye RA, Pandita TK, et al. hSIR2SIRT1 functions as NAD-dependent p53 deacetylase. Cell. 2001;107:149-59. (Pubitemid 33035942)
10. Kahyo T, Mostoslavsky R, Goto M, Setou M. Sirtuin-mediated deacetylation pathway stabilizes Werner syndrome protein. FEBS Lett. 2008;582:2479-83.
11. Li K, Casta A, Wang R, Lozada E, Fan W, Kane S, et al. Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J Biol Chem. 2008;283:7590-8.
12. Tikoo K, Bhatt DK, Gaikwad AB, Sharma V, Kabra DG. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats. FEBS Lett. 2007;581:2027-35. (Pubitemid 46670130)
13. Ozaki K, Kishikawa F, Tanaka M, Sakamoto T, Tanimura S, Kohno M. Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs. Cancer Sci. 2008;99:376-84. (Pubitemid 351228495)
14. Arany I, Herbert J, Herbert Z, Safirstein RL. Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells. Am J Physiol Renal Physiol. 2008;294:F577-81.
15. Dong G, Wang L, Wang CY, Yang T, Kumar MV, Dong Z. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. J Pharmacol Exp Ther. 2008;325:978-84. (Pubitemid 351724333)
16. Zager RA, Johnson ACM. Renal ischemia-reperfusion injury upregulates histone modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol. 2009;296:F1032-41.
17. Matsushita N, Takami Y, Kimura M, Tachiiri S, Ishiai M, Nakayama T, et al. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells. Genes Cells. 2005;10:321-32. (Pubitemid 40443684)
18. Kojima K, Ohhashi R, Fujita Y, Hamada N, Akao Y, Nozawa Y, et al. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Com. 2008;373:423-8.
19. Liang XJ, Finkel T, Shen DW, Yin JJ, Aszalos A, Gottesman MM. SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism. Mol Cancer Res. 2008;6:1499-506.
20. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, et al. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Com. 2008;372:51-6.
21. Amaral CLD, Francescato HDC, Coimbra TM, Costa RS, Darin JD, Antunes LM, et al. Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. Arch Toxicol. 2008;82:363-70.
22. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res. 2007;100:1512-21. (Pubitemid 46834764)
23. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem. 2010;285:13045-56.
24. Dong G, Luo J, Kumar V, Dong Z. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. Am J Physiol Renal Physiol. 2010;298:F293-300.
25. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, et al. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med. 2006;40:2175-82. (Pubitemid 43903102)
26. Kume S, Uzu T, Horiike K, Chin-Kanasaki M, Isshiki K, Araki S, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest. 2010;120:1043-55.
27. Inoue K, Kuwana H, Shimamura Y, Ogata K, Taniguchi Y, Kagawa T, et al. Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol. 2010;14:112-22.
28. Cheng WH, Muftuoglu M, Bohr VA. Werner syndrome protein: functions in the response to DNA damage and replication stress in S-phase. Exp Gerontol. 2007;42:871-8. (Pubitemid 47268735)
29. Rodriguez-Lopez AM, Jackson DA, Nehlin JO, Iborra F, Warren AV, Cox LS, et al. Characterization of the interaction between WRN the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA. Mech Ageing Dev. 2003;124:167-74.
30. Gregoire S, Xiao L, Nie J, Zhang X, Xu M, Li J, et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol. 2007;27:1280-95. (Pubitemid 46239812)
31. Shao Y, Lu J, Cheng C, Cui L, Zhang G, Huang B. Reversible histone acetylation involved in transcriptional regulation of WT1 gene. Acta Biochi Biophys Sinica. 2007;39:931-8. (Pubitemid 350274283)
32. Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, Fujita T. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol. 2010;298:F133-41.